等待开盘 08-15 09:30:00 美东时间
-0.450
-0.38%
今日重点评级关注:韦德布什:维持Gossamer Bio"跑赢大市"评级,目标价从4美元升至5美元;HC Wainwright & Co.:维持EyePoint Pharmaceuticals"买入"评级,目标价从22美元升至23美元
08-07 09:46
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma
08-07 02:28
Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price target from $165 to $162.
08-07 00:22
Jazz Pharmaceuticals (NASDAQ:JAZZ) raises FY2025 GAAP EPS guidance from $(10.00)-$(7.50) to $(9.25)-$(7.50) vs $(9.15) analyst estimate..
08-06 04:09
Jazz Pharmaceuticals (NASDAQ:JAZZ) lowers FY2025 Adj EPS guidance from $20.50-$22.10 to $4.80-$5.60 vs $4.94 analyst estimate. Narrows FY2025 sales outlook from $4.150 billion-$4.400 billion to $4.150 billion-$4.300
08-06 04:09
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earning...
08-02 01:04
8 analysts have expressed a variety of opinions on Jazz Pharmaceuticals (NASDAQ...
07-22 21:01
Morgan Stanley analyst Jeffrey Hung maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price target from $166 to $165.
07-22 20:54
Jazz Pharmaceuticals (($JAZZ)) announced an update on their ongoing clinical st...
07-18 00:26